BURRELL INTERNATIONAL GROUP LLC

Lobbying for BIOFACTURA, INC. · Biopharmaceutical industry development, scale-up, and manufacturing

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $10,000.00 income · posted Oct 18, 2025

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Medical Countermeasure Development for Smallpox and FY26 LHHS Appropriation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.